NCT03457935进行中（未招募）不适用
The Role of the miR200 Family in the Restoration of Normal Lung Homeostasis and Detection of Early IPF
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 450
- 试验地点
- 1
- 主要终点
- To determine miR200 levels (fold change) in blood samples.
研究概览
简要总结
The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •Hepatitis B
- •Hepatitis C
- •Pregnant or lactating women
- •inclusion criteria for controls: informed consent >18 years old; no lung diseases
结局指标
主要结局
To determine miR200 levels (fold change) in blood samples.
时间窗: Baseline (one time).
MicroRNAs (miRs) are noncoding small RNAs, which regulate numerous physiological and pathological processes. miR200 levels will be measured in blood samples collected from control subjects, non-IPF ILD and IPF patients. These samples will be used for identifying biomarkers for IPF.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Specific microRNAs as Potential Biomarker for Inflammatory Bowel DiseaseUlcerative ColitisCrohn's DiseaseNCT03698500University Hospital Muenster350
撤回
不适用
MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host DiseaseAcute GVH DiseaseNCT02917148Northwell Health
尚未招募
Unknown
Evaluation of miRNA -210 as prognostic marker of pre-eclampsiaCTRI/2023/10/059019DR KOTA SAI MEGHANA
已完成
2 期
A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic CancerPancreatic CancerNCT00674973Hoffmann-La Roche207
已完成
不适用
Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD)Inflammatory Bowel DiseasesNCT04256538Second Affiliated Hospital, School of Medicine, Zhejiang University179